Clinical trial · Observational
To Perform a Post-market Study of the Performance of the Idylla ThyroidPrint Assay Using Clinical Samples in Predicting the Nature of Indeterminate Thyroid Nodules (ITNs) Across Multiple Centers.
Idylla™ ThyroidPrint® RUO Assay Beta-Trial Study
NCT06849284CI-TRIAL-00090526recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To perform a post-market study of the performance of the Idylla™ ThyroidPrint® Assay using clinical samples in predicting the nature of indeterminate thyroid nodules (ITNs) across multiple centers.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Thyroid Cancer | Malignant Thyroid Gland Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Primary endpoints
- timeFrame
- Samples taken at Baseline
- description
- to measure the accuracy of the Thyroid print test against the surgical pathology report.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Thyroid nodule ≥1.0 cm * With indeterminate cytology * Surgery due to be performed Exclusion Criteria: * Specimens which fail to meet the inclusion criteria. * FNA fixed in formalin or transferred in alcohol-based collection buffers which is not according to the protocol instructions. * RNA extracts. * Patients with ultrasound evidence of malignant cervical adenopathy
References
Publications (0)
Data not yet available
No reference posted for this study.